Cancer Research

Radioactive 'Seeds' May Lead To Better Lung Cancer Prognosis

A new method of treatment could mean a dramatic difference in the way we look at and treat lung cancer. Developed over the past decade, a team of researchers at Allegheny General Hospital (AGH) in Pittsburgh has developed a new technique using a mesh of ra ...

Article - Erin Richards - Dec 15 2008 - 1:39am

Merck Serono Recognized For Strategic Leadership In Human Resources

GENEVA, Switzerland, September 29 /PRNewswire/--- Award Highlights Successful Global HR Approach During Company Integration Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has won the prestigious "Human Capital Lea ...

Article - Anna Ohlden - Sep 29 2008 - 4:33am

Appointment Notice- Comprehensive Care International Appoints Healthcare Executive Anthony DiCaita As Project Director For Chil

TORONTO, September 29 /PRNewswire/-- Comprehensive Care International (CCI), is pleased to announce the appointment of Anthony DiCaita, CMA, CHE, MBA, MPA, as Project Director for the Children's Cancer Hospital (CCH) 57357 project in Cairo, Egypt. Mr ...

Article - Anna Ohlden - Sep 29 2008 - 8:33am

Mass-Produced Smell Receptors Could Mean Artificial Noses

Smell is one of the most complex and least-understood senses. Humans have a vast olfactory system that includes close to 400 functional genes, more than are dedicated to any other function. Animals such as dogs and mice have around 1,000 functional olfacto ...

Article - News Staff - Sep 29 2008 - 4:43pm

Hormone Replacement Therapy And The Risk Of Heart Attacks

It's not what you take but the way that you take it that can produce different results in women who take hormone replacement therapy (HRT), according to new research on the association between HRT and heart attacks, published the European Heart Journ ...

Article - News Staff - Sep 30 2008 - 10:35pm

Understanding Apoptosis In Cells May Lead To A Cancer Breakthrough

When a cell's chromosomes lose their ends, the cell usually kills itself to stem the genetic damage- University of Utah biologists say their discovery about how those cells evade suicide and start down the path to cancer may lead to new treatments. A ...

Article - News Staff - Sep 30 2008 - 11:16pm

Lumiphore Partners With Biophor Diagnostics, Inc. To Develop Tests For Drugs Of Abuse; Appoints Ibis Biosciences Founder David J

RICHMOND, California, October 1 /PRNewswire/-- Lumiphore, Inc., a biotechnology leader in the development of new proprietary fluorescent metal-lanthanide technology for use in high-value applications, announced that it has signed an exclusive agreement wi ...

Article - Anna Ohlden - Oct 1 2008 - 1:30am

ImmunoVaccine Technologies' DepoVax(TM) Shows Positive Results For Cancer And Infectious Diseases

HALIFAX, Canada, October 1 /PRNewswire/-- ImmunoVaccine Technologies' (IVT) patented depot vaccine formulation, DepoVax(TM) is showing positive pre-clinical results, with single-dose efficacy achieved in therapeutic cancer and several infectious dise ...

Article - Anna Ohlden - Oct 1 2008 - 8:33am

Bayer's Novel Oral Anticoagulant Xarelto(R) (Rivaroxaban) Gets European Licence

NEWBURY, England, October 2 /PRNewswire/--- New Drug Xarelto(R) (Rivaroxaban), Which has Been Shown to be Significantly More Effective Than Current Standard, Gets UK Licence A new drug launched today could help in the fight against what experts and campai ...

Article - Anna Ohlden - Oct 2 2008 - 6:34am

Severe Adverse Event Reported In Raptiva(R) Patient

GENEVA, Switzerland, October 2 /PRNewswire/-- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Genentech Inc. has reported a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had received ...

Article - Anna Ohlden - Oct 2 2008 - 5:30pm